- Astex applies Pyramid to Schering AG protein targets
- Astex, AstraZeneca enter CNS drug discovery collaboration
- Astex signs drug discovery deal with Cancer Research UK
- Eli Lilly licenses 3-D technology from Structural GenomiX
- RTS to improve, sell Syrrx's platform technology
- Astex evaluates Aventis Pharmaceuticals' compounds
- Astex, AstraZeneca evaluate AZ's compounds
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.